Schroders Valuation

Is PYXB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PYXB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PYXB (€3.62) is trading below our estimate of fair value (€6.58)

Significantly Below Fair Value: PYXB is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PYXB?

Key metric: As PYXB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PYXB. This is calculated by dividing PYXB's market cap by their current earnings.
What is PYXB's PE Ratio?
PE Ratio13.1x
EarningsUK£376.50m
Market CapUK£4.93b

Price to Earnings Ratio vs Peers

How does PYXB's PE Ratio compare to its peers?

The above table shows the PE ratio for PYXB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.1x
DWS DWS Group GmbH KGaA
13.4x13.1%€8.0b
MLP MLP
10.8x6.4%€654.7m
AR4 AURELIUS Equity Opportunities SE KGaA
3.9xn/a€384.2m
DBAN Deutsche Beteiligungs
24.5x54.1%€421.5m
PYXB Schroders
13.1x12.9%€4.9b

Price-To-Earnings vs Peers: PYXB is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (13.1x).


Price to Earnings Ratio vs Industry

How does PYXB's PE Ratio compare vs other companies in the DE Capital Markets Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
AR4 AURELIUS Equity Opportunities SE KGaA
3.9xn/aUS$403.94m
HXCK Ernst Russ
3.1x-23.5%US$201.17m
VG8 Varengold Bank
2xn/aUS$25.76m
XE8 Black Sea Property
0.7xn/aUS$7.75m
No more companies available in this PE range
PYXB 13.1xIndustry Avg. 20.7xNo. of Companies6PE01632486480+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PYXB is good value based on its Price-To-Earnings Ratio (13.1x) compared to the German Capital Markets industry average (20.7x).


Price to Earnings Ratio vs Fair Ratio

What is PYXB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PYXB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.1x
Fair PE Ratio17.2x

Price-To-Earnings vs Fair Ratio: PYXB is good value based on its Price-To-Earnings Ratio (13.1x) compared to the estimated Fair Price-To-Earnings Ratio (17.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PYXB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€3.62
€4.59
+26.8%
11.9%€5.96€3.79n/a15
Nov ’25€4.11
€4.81
+17.1%
11.4%€5.91€4.11n/a15
Oct ’25€4.18
€4.80
+14.8%
11.8%€5.95€4.14n/a15
Sep ’25€4.09
€4.72
+15.5%
11.7%€5.80€4.10n/a15
Aug ’25€4.57
€4.91
+7.3%
13.0%€5.90€4.13n/a15
Jul ’25€4.37
€4.92
+12.6%
11.8%€5.95€4.12n/a15
Jun ’25€4.58
€4.89
+6.8%
12.1%€5.94€4.11n/a15
May ’25€4.18
€5.02
+20.1%
10.4%€5.90€4.21n/a15
Apr ’25€4.34
€5.11
+17.7%
10.4%€5.91€4.33n/a15
Mar ’25€4.60
€5.20
+13.1%
9.6%€6.00€4.32n/a16
Feb ’25€4.74
€5.27
+11.2%
9.3%€6.04€4.40n/a16
Jan ’25€5.01
€5.21
+3.9%
10.0%€6.06€4.07n/a16
Dec ’24€4.64
€5.12
+10.3%
9.3%€5.95€4.04n/a16
Nov ’24€4.23
€5.06
+19.6%
9.3%€5.91€4.02€4.1115
Oct ’24€4.65
€5.36
+15.4%
8.9%€6.21€4.40€4.1815
Sep ’24€4.83
€5.36
+11.0%
8.7%€6.26€4.44€4.0915
Aug ’24€5.34
€5.43
+1.8%
8.4%€6.28€4.79€4.5715
Jul ’24€5.01
€5.37
+7.3%
8.4%€6.39€4.68€4.3714
Jun ’24€5.36
€5.37
+0.3%
8.4%€6.39€4.68€4.5814
May ’24€5.37
€5.37
-0.01%
8.4%€6.39€4.68€4.1814
Apr ’24€5.18
€5.40
+4.3%
7.2%€6.02€4.83€4.3414
Mar ’24€5.64
€5.33
-5.4%
9.0%€6.24€4.48€4.6014
Feb ’24€5.40
€5.33
-1.2%
9.0%€6.24€4.48€4.7414
Jan ’24€5.10
€5.43
+6.5%
8.6%€6.02€4.53€5.0113
Dec ’23€5.15
€5.45
+5.7%
9.2%€6.09€4.37€4.6413
Nov ’23€4.56
€5.57
+22.1%
9.5%€6.51€4.38€4.2314

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies